In a first, Glenmark Pharma launches pulmonary fibrosis treatment drug in India at affordable cost, clinical trials being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced pulmonary fibrosis in moderate to severe COVID-19 patients
from Hindustan Times - lifestyle https://ift.tt/3k0wQhW
Post Top Ad
Tuesday, 13 October 2020
India gets affordable drug to treat pulmonary fibrosis, Glenmark Pharma launches...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment